JNJ completes Firefly acquisition, enters Sail collaboration; cuts 2026 EPS guidance by $0.64

JOHNSON & JOHNSON

2026 adjusted operational EPS midpoint lowered to $10.94 from $11.58; adjusted EPS midpoint to $11.04 from $11.68.
Firefly acquisition reduces 2026 EPS by ~$0.46; Sail collaboration reduces by ~$0.18.
2027 adjusted EPS expected to decrease by ~$1.36 ($0.08 Firefly, $1.28 Sail assuming milestones).
Operational sales guidance maintained at $100.3B-$100.9B; adjusted pre-tax operating margin guidance cut by ~150 bps.
Transactions include completion of Firefly Bio acquisition and strategic agreements with Sail Biomedicines.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.